A Study of Moderate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world Setting
Clinical trial NCT05787236 · COMPLETED
Trial details
- NCT number
- NCT05787236
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-05
- Primary completion
- 2022-03-15
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.